On the 40th anniversary of the discovery of Helicobacter pylori
https://doi.org/10.52888/0514-2515-2022-353-2-121-134
Abstract
The review is dedicated to the analysis of the accumulated data on the study of Helicobacter pylori (H. pylori) since the detailed description of this bacterium as the main etiological factor of gastrointestinal diseases. The work shows the dual role of H. pylori both as a bacterial pathogen for humans and as a potential representative of the normal microbiome of the stomach. In most scientific publications, the attention of researchers is focused entirely on the consideration of the pathogenic properties of H. pylori in the development of chronic gastritis, peptic ulcer disease (PUD) and gastric cancer (GC), and also considers the development of effective methods of eradication therapy. Along with this, in recent years, more and more often there are works that indicate a potentially positive effect of this bacterium on the human body and the occurrence of a number of negative consequences after eradication therapy. In this connection, the question of the probable affiliation of H. pylori to the composition of the human microbiome is discussed. Data on the high prevalence of the microorganism in the population and its asymptomatic coexistence with humans indicate the persistence of the bacterium in the body, most likely as a representative of the microbiome. The accumulated data on the effect of H. pylori on human health demonstrate a clear ambiguity of the problem. In this regard, it is important to answer the question whether it is necessary to create programs for mass eradication of H. pylori, or whether it is necessary to approach the implementation of eradication therapy in a more personalized way.
About the Authors
V. I. Reshetnyak
Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Vasily Ivanovich Reshetnyak, Doctor of Medical Sciences, Professor
A. I. Yevdokimov Moscow State University of Medicine and Dentistry
Department of Propaedeutics of Internal Diseases and Gastroenterology
Moscow
A. I. Burmistrov
Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
A. I. Yevdokimov Moscow State University of Medicine and Dentistry
Moscow
References
1. Blaser M. J. Исчезающая микробиота / M. J. Blaser, S. Falkow // Клиническая фармакология и терапия. – 2014. –23 (4): 7-16. [Blaser M. J., Falkow S. Disappearing microbiota. Clin Pharmacol Ther. 2014; 4: 7-16 (In Russ.)]
2. Герман С. В. Новые аспекты пилорической хеликобактерной инфекции: связь с метаболическими нарушениями / С. В. Герман, И. П. Бобровницкий //Терапевтический архив. – 2017. – 89 (10): 102-107. [German S. V., Bobrovnitsky I. P. New aspects of Helicobacter pylori infection: Association with metabolic disturbances. Ter Arkh. 2017; 89 (10): 102-107 (In Russ.)]. DOI: 10.17116/terarkh20178910102-107
3. Маев И. В. Клиническое значение инфекции Helicobacter pylori / И. В. Маев [и др.] // Клиническая медицина. –2013/ –91 (8): 4-12. [Maev I. V., Samsonov A. A., Andreev D. N., Grechushnikov V. B., Korovina T. I. Clinical significance of Helicobacter pylori infection. Clinical Medicine. 2013; 91 (8): 4-12 (In Russ.)]
4. Роккас Ф. Инфекция Helicobacter pylori как фактор риска рака желудка: современные доказательства / Ф. Роккас // Росс журн. гастроэнтерол. гепатол. колопроктол. – 2002: 3. – 66-70. [Rokkas F. Helicobacter pylori infection as risk factor of a carcinoma of the stomach: current evidence. Russ J Gastroenterol Hepatol Coloproctol. 2002; 3: 66-70 (in Russ.)]
5. Сидоренко С. В. Диагностика и лечение инфекций, вызываемых Helicobacter pylori / С. В. Сидоренко. – В кн.: Инфекции в амбулаторной практике. – М., 2002: 125-140. [Sidorenko S. V. Diagnosis and treatment of infections caused by Helicobacter pylo- ri. In: Infections in outpatient practice. M., 2002: 125-40 (In Russ.)]
6. Циммерман Я. С. Рак желудка: современный взгляд на проблему / Я. С. Циммерман // Вестн. хир. гастроэнтерол. – 2011. – 2: 77-88. [Tsimmerman Ya. S. Gastric cancers: a modern approach to the problem. Vestnik chirurgicheskoj gastroenterologii. 2011; 2: 77-88 (in Russ.)]
7. Циммерман Я. С. Критический анализ концепции о ведущей роли Helicobacter pylori инфекции в развитии гастродуоденальных заболеваний / Я. С. Циммерман // Клин. фармакол. тер. – 2019. – 28 (2): 19-27. [Tsimmerman Ya. S. Critical analysis of the Helicobacter pylori-infection leading role in the development of gastroduodenal diseases. Clin pharmacol ther. 2019; 28 (2): 19-27 (In Russ.)]. DOI: 10.32756/0869-5490-2019-2-19-27
8. Altobelli A., Bauer M., Velez K., Cover T. L., Müller A. Helicobacter pylori VacA Targets Myeloid Cells in the Gastric Lamina Propria To Promote Peripherally Induced Regulatory T-Cell Differentiation and Persistent Infection. mBio. 2019; 10 (2): e00261-19. DOI: 10.1128/mBio.00261-19
9. Ansari S., Yamaoka Y. Survival of Helicobacter pylori in gastric acidic territory. Helicobacter. 2017; 22 (4): 10.1111/hel.12386. DOI: 10.1111/hel.12386
10. Bor S., Kitapcioglu G., Kasap E. Prevalence of gastroesophageal reflux disease in a country with a high occurrence of Helicobacter pylori. World J Gastroenterol. 2017; 23 (3): 525-532. DOI: 10.3748/wjg.v23.i3.525
11. Burucoa C., Axon A. Epidemiology of Helicobacter pylori infection. Helicobacter. 2017; 22 (1 Suppl.). DOI: 10.1111/hel.12403
12. Cárdenas V. M., Boller F., Román G. C. Helicobacter pylori, Vascular Risk Factors and Cognition in U. S. Older Adults. Brain Sci. 2019; 9 (12): 370. DOI: 10.3390/brainsci9120370
13. Chang W. L., Yeh Y. C., Sheu B. S. The impacts of H. pylori virulence factors on the development of gastroduodenal diseases. J Biomed Sci. 2018; 25 (1): 68. DOI: 10.1186/s12929-018-0466-9
14. Cover T. L., Blaser M. J. Helicobacter pylori in health and disease. Gastroenterology. 2009;136 (6): 1863-1873. DOI: 10.1053/j.gastro.2009.01.073
15. Crowe S. E. Helicobacter pylori Infection. N Engl J Med. 2019; 380: 1158-1165. DOI: 10.1056/NEJMcp1710945
16. de Jesus Souza M., de Moraes J. A., Da Silva V. N., Helal-Neto E., Uberti A. F., Scopel-Guerra A., et al. Helicobacter pylori urease induces pro-inflammatory effects and differentiation of human endothelial cells: Cellular and molecular mechanism. Helicobacter. 2019; 24 (3): e12573. DOI: 10.1111/hel.12573
17. Elias N., Nasrallah E., Khoury C., Mansour B., Abu Zuher L., Asato V., et al. Associations of Helicobacter pylori seropositivity and gastric inflammation with pediatric asthma. Pediatr Pulmonol. 2020; 10.1002/ppul.24905. DOI: 10.1002/ppul.24905
18. Ertz-Archambault N., Keim P., Von Hoff D. Microbiome and pancreatic cancer: A comprehensive topic review of literature. World J Gastroenterol. 2017; 23 (10): 1899-1908. DOI: 10.3748/wjg.v23.i10.1899
19. Fernandes Y. C., Bonatto Gda R., Bonatto M. W. Recurrence rate of Helicobacter pylori in patients with peptic ulcer five years or more after successful eradication. Arq Gastroenterol. 2016; 53 (3): 152-155. DOI: 10.1590/S0004-28032016000300006
20. Franceschi F., Covino M., Roubaud Baudron C. Review: Helicobacter pylori and extragastric diseases. Helicobacter. 2019; 24 (1 Suppl):e12636. DOI: 10.1111/hel.12636
21. Gravina A. G., Zagari R. M., De Musis C., Romano L., Loguercio C., Romano M. Helicobacter pylori and extragastric diseases: A review. World J Gastroenterol. 2018; 24 (29): 3204-3221. DOI: 10.3748/wjg.v24.i29.3204
22. Gu H. Role of Flagella in the Pathogenesis of Helicobacter pylori. Curr Microbiol. 2017;74 (7): 863-869. DOI: 10.1007/s00284-017-1256-4
23. Gupta N., Maurya S., Verma H. Unraveling the factors and mechanism involved in persistence: Host-pathogen interactions in Helicobacter pylori. J Cell Biochem. 2019; 120 (11): 18572-18587. DOI: 10.1002/jcb.29201
24. Hathroubi S., Zerebinski J., Ottemann K. M. Helicobacter pylori Biofilm Involves a Multigene Stress-Biased Response, Including a Structural Role for Flagella. mBio. 2018; 30; 9 (5): e01973-18. URL: https://pubmed.ncbi.nlm.nih.gov/30377283/
25. Hooi J. K. Y., Lai W. Y., Ng W. K., Suen M. M. Y., Underwood F. E., Tanyingoh D., et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017; 153 (2): 420-429. DOI: 10.1053/j.gastro.2017.04.022
26. Hsu W. T., Ho S. Y., Jian T. Y., Huang H. N., Lin Y. L., Chen C. H., et al. Helicobacter pylori-derived heat shock protein 60 increases the induction of regulatory T-cells associated with persistent infection. Microb Pathog. 2018; 119: 152-161. DOI: 10.1016/j.micpath.2018.04.016
27. Huang H. K., Wang J. H., Lei W. Y., Chen C. L., Chang C. Y., Liou L. S. Helicobacter pylori infection is associated with an increased risk of Parkinson's disease: A population-based retrospective cohort study. Parkinsonism Relat Disord. 2018; 47: 26-31. DOI: 10.1016/j.parkreldis.2017.11.331
28. Hunt R. H., Yaghoobi M. The esophageal and gastric microbiome in health and disease. Gastroenterol Clin. 2017; 46 (1): 121-141. DOI: 10.1016/j.gtc.2016.09.009
29. Ierardi E., Losurdo G., Giorgio F., Di Leo A. Might helicobacter pylori play a role in allergic or cross-reaction related disorders?. Expert Rev Gastroenterol Hepatol. 2020; 14 (8): 643-646. DOI: 10.1080/17474124.2020.1780119
30. Javed S., Skoog E. C., Solnick J. V. Impact of Helicobacter pylori Virulence Factors on the Host Immune Response and Gastric Pathology. Curr Top Microbiol Immunol. 2019; 421: 21-52. DOI: 10.1007/978-3-030-15138-6_2
31. Jemilohun A. C., Otegbayo J. A. Helicobacter pylori infection: past, present and future. Pan Afr Med J. 2016; 23: 216. DOI: 10.11604/pamj.2016.23.216.8852
32. Jukic A., Bozic D., Kardum D., Becic T., Luksic B., Vrsalovic M., et al. Helicobacter pylori infection and severity of coronary atherosclerosis in patients with chronic coronary artery disease. Ther Clin Risk Manag. 2017; 13: 933-938. DOI: 10.2147/TCRM.S142193
33. Kanno T., Iijima K., Abe Y., Yagi M., Asonuma S., Ohyauchi M., et al. Helicobacter pylori-negative and non-steroidal anti-inflammatory drugs-negative idiopathic peptic ulcers show refractoriness and high recurrence incidence: Multicenter follow-up study of peptic ulcers in Japan. Dig Endosc. 2016; 28: 556-563. DOI: 10.1111/den.12635
34. Lehours P., Ferrero R. L. Review: Helicobacter: Inflammation, immunology, and vaccines. Helicobacter. 2019; 24 (1 Suppl.): e12644. DOI: 10.1111/hel.12644
35. Li J., Perez-Perez G. I. Helicobacter pylori the Latent Human Pathogen or an Ancestral Commensal Organism. Front Microbiol. 2018; 9: 609. DOI: 10.3389/fmicb.2018.00609
36. Liu J., He C., Chen M., Wang Z., Xing C, Yuan Y. Association of presence/absence and on/off patterns of Helicobacter pylori oipA gene with peptic ulcer disease and gastric cancer risks: a meta-analysis. BMC Infect Dis. 2013; 13: 555. DOI: 10.1186/1471-2334-13-555
37. Maleki Kakelar H., Barzegari A., Dehghani J., Hanifian S., Saeedi N., Barar J., et al. Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination. Gastric Cancer. 2019; 22 (1): 23-36. DOI: 10.1007/s10120-018-0867-1
38. Malnick S. D., Melzer E., Attali M., Duek G., Yahav J. Helicobacter pylori: friend or foe?. World J Gastroenterol. 2014; 20 (27): 8979-8985. DOI: 10.3748/wjg.v20.i27.8979
39. Marcus E. A., Sachs G., Scott D. R. Acid-regulated gene expression of Helicobacter pylori: Insight into acid protection and gastric colonization. Helicobacter. 2018; 23 (1 Suppl.): e12490. URL: https://pubmed.ncbi.nlm.nih.gov/29696729/.
40. Matsuo Y., Kido Y., Yamaoka Y. Helicobacter pylori outer membrane protein‐related pathogenesis. Toxins. 2017; 11; 9 (3): 101. DOI: 10.3390/toxins9030101
41. Mentis A. A., Boziki M., Grigoriadis N., Papavassiliou A. G. Helicobacter pylori infection and gastric cancer biology: tempering a double-edged sword. Cell Mol Life Sci. 2019; 76 (13): 2477-2486. DOI: 10.1007/s00018-019-03044-1
42. Miftahussurur M., Nusi I. A., Graham D. Y., Yamaoka Y. Helicobacter, Hygiene, Atopy, and Asthma. Front Microbiol. 2017; 8: 1034. DOI: 10.3389/fmicb.2017.01034
43. Mladenova I., Durazzo M. Transmission of Helicobacter pylori. Minerva Gastroenterol Dietol. 2018; 64 (3): 251-254. DOI: 10.23736/S1121-421X.18.02480-7
44. Mungan Z., Pınarbaşı Şimşek B. Gastroesophageal reflux disease and the relationship with Helicobacter pylori. Turk J Gastroenterol. 2017; 28 (1Suppl): S61-S67. DOI: 10.5152/tjg.2017.16
45. Pachathundikandi S. K., Müller A., Backert S. Inflammasome Activation by Helicobacter pylori and Its Implications for Persistence and Immunity. Curr Top Microbiol Immunol. 2016; 397: 117-131. DOI: 10.1007/978-3-319-41171-2_6
46. Rasane R. K., Horn C. B., Coleoglou Centeno A. A., Fiore N. B., Torres Barboza M., Zhang Q. Are Patients with Perforated Peptic Ulcers Who are Negative for Helicobacter pylori at a Greater Risk?. Surg Infect (Larchmt). 2019; 20 (6): 444-448. DOI: 10.1089/sur.2018.249
47. Reshetnyak T. M., Doroshkevich I. A., Seredavkina N. V., Nasonov E. L., Maev I. V., Reshetnyak V. I. The Contribution of Drugs and Helicobacter pylori to Gastric Mucosa Changes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Int J Rheumatol. 2019; 2019: 9698086. DOI: 10.1155/2019/9698086
48. Reshetnyak V. I., Reshetnyak T. M. Significance of dormant forms of Helicobacter pylori in ulcerogenesis. World J Gastroenterol. 2017; 23 (27): 4867-4878. DOI: 10.3748/wjg.v23.i27.4867
49. Rokkas T., Gisbert J. P., Niv Y., O'Morain C. The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis. United European Gastroenterol J. 2015; 3 (6): 539-550. DOI: 10.1177/2050640615580889
50. Sgambato D., Visciola G., Ferrante E., Miranda A., Romano L., Tuccillo C. Prevalence of Helicobacter pylori infection in sexual partners of H. pylori-infected subjects: Role of gastroesophageal reflux. United European Gastroenterol J. 2018; 6 (10): 1470-1476. DOI: 10.1177/2050640618800628
51. Tsigalou C., Konstantinidis T. G., Cassimos D., Karvelas A., Grapsa A., Tsalkidis A. Inverse association between Helicobacter pylori infection and childhood asthma in Greece: a case-control study. Germs. 2019; 9 (4): 182-187. DOI: 10.18683/germs.2019.1174
52. Wu X. W., Ji H. Z., Yang M. F., Wu L., Wang F. Y. Helicobacter pylori infection and inflammatory bowel disease in Asians: a meta-analysis. World J Gastroenterol. 2015; 21 (15): 4750-4756. DOI: 10.3748/wjg.v21.i15.4750
53. Yu M., Zhang R., Ni P., Chen S., Duan G. Helicobacter pylori Infection and Psoriasis: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2019; 55 (10): 645. DOI: 10.3390/medicina55100645
54. Zamani M., Vahedi A., Maghdouri Z., Shokri-Shirvani J. Role of food in environmental transmission of Helicobacter pylori. Caspian J Intern Med. 2017; 8 (3): 146-152. DOI: 10.22088/cjim.8.3.146
55. Zhao Y., Li Y., Hu J., Wang X., Ren M., Lu G., et al. The Effect of Helicobacter pylori Eradication in Patients with Gastroesophageal Reflux Disease: A Meta-Analysis of Randomized Controlled Studies. Dig Dis. 2020; 38: 261-268. DOI: 10.1159/000504086
Review
For citations:
Reshetnyak V.I., Burmistrov A.I. On the 40th anniversary of the discovery of Helicobacter pylori. Health care of Tajikistan. 2022;(2):120-133. (In Russ.) https://doi.org/10.52888/0514-2515-2022-353-2-121-134
Views:
577
Email this article 